- Home
- ORKT
ORKT
ORANGEKLOUD TECHNOLOGY INC
as 04-23-2025 4:00pm EST
Stocks
| Founded: | 2003 | Country: | Singapore |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2024 |
| Target Price: | $5.00 | AVG Volume (30 days): | 98.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.51 - $8.00 | Next Earning Date: | 01-01-0001 |
| Revenue: | $3,904,592 | Revenue Growth: | -23.56% |
| Revenue Growth (this year): | -48.01% | Revenue Growth (next year): | 39.99% |
Latest ORANGEKLOUD TECHNOLOGY INC News
ORKT Breaking Stock News: Dive into ORKT Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 months ago
Orangekloud Pioneers the Future of AI-Driven No-Code Development with Beta Launch of eMOBIQ® AI
GlobeNewswire
6 months ago
Orangekloud Technology Appoints Mr. Toh Puay-Yong as Chief Financial Officer
GlobeNewswire
6 months ago
Orangekloud Introduces AI-Powered No-Code Application Development Platform at GITEX Global
TipRanks
6 months ago
Orangekloud, ELITC enter partnership agreement
GlobeNewswire
6 months ago
Orangekloud Technology Inc. and Electronics Industries Training Centre (ELITC) Ink Partnership Agreement to Empower Workforce Skills Development and Digital Transformation in Singapore
GlobeNewswire
6 months ago
Orangekloud Technology Signs S$1M Strategic Investment in Award-Winning Cybersecurity Firm, Evvo Labs
GlobeNewswire
7 months ago
Orangekloud SaaS Solutions to be Distributed in South Africa via MOU Signed with JPJ Medical
GlobeNewswire
8 months ago
OrangeKloud partners with AI Singapore (AISG) to enhance No-Code App Building Technology with Artificial Intelligence
Compare ORKT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORKT ORANGEKLOUD TECHNOLOGY INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.